Public Accounts Committee

Publications - Price increases for generic medications inquiry

Inquiry status: open

Oral evidence

  • 04 Jul 2018 - Price increases for generic medications - oral evidence | PDF version (PDF309 KB) HC 1184 | Published 15 Oct 2018

    Evidence given by Mark Burdon, Regional Representative, North East and Cumbria, Pharmaceutical Services Negotiating Committee, Warwick Smith, Director General, British Association of Generic Manufacturers, and Professor Karim Meeran, Deputy Director of Medical Education, Imperial College; Sir Chris Wormald, Permanent Secretary, Steve Oldfield, Chief Commercial Officer, Department of Health and Social Care, Dr Bruce Warner, Deputy Chief Pharmaceutical Officer, NHS England, and Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency (at 3.15pm).

    Watch this evidence session

Receive RSS updates

Share this page